Organization
Innocoll
2 clinical trials
Clinical trial
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of a 300-mg Dose of the INL-001 (Bupivacaine Hydrochloride) Implant in Patients Undergoing AbdominoplastyStatus: Completed, Estimated PCD: 2021-10-27
Clinical trial
An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Open Ventral Hernia Repair, Abdominoplasty, Open Abdominal Hysterectomy, Laparoscopic-assisted Colectomy, and Reduction MammoplastyStatus: Completed, Estimated PCD: 2023-01-10